Rita Anzalone

Rita Anzalone

Auto-generated profile, based on publicly available information

Rita Anzalone

Department of Experimental Biomedicine and Clinical Neuroscience, University of Palermo, 90100 Palermo, Italy

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2008 in Histochemistry and Cell Biology
Verified
Journal Article
Closed access
PDF file
GRGiampiero La Rocca
Giampiero La Rocca
RARita Anzalone
Rita Anzalone
SCSimona CORRAO
Simona CORRAO
FMFrancesca Magno
Francesca Magno
TLTiziana Loria
Tiziana Loria
FFFelicia Farina
Felicia Farina

1 April 2010 in Stem Cells and Development
Verified
Journal Article
Closed access
RARita Anzalone
Rita Anzalone
MIMelania Lo Iacono
Melania Lo Iacono
SCSimona CORRAO
Simona CORRAO
FMFrancesca Magno
Francesca Magno
TLTiziana Loria
Tiziana Loria
GRGiampiero La Rocca
Giampiero La Rocca
In recent years, human mesenchymal stem cells (MSC) have been extensively studied. Their key characteristics of long-term self-renewal and a capacity to differentiate into diverse mature tissues favor their use in regenerative medicine applications. Stem cells can be found in embryonic and extraembryonic tissues as well as in adult organs. Several reports indicate that cells of Wharton’s jelly (WJ), the main component of umbilical cord extracellular matrix, are multipotent stem cells, expressing markers of bone marrow mesenchymal stem cells (BM-MSC), and giving rise to different cellular types of both connective and nervous tissues. Wharton’s jelly mesenchymal stem cells (WJ-MSC) express markers previously characterized in embryonic stem cells (ESC), such as Nanog and Oct3/4A. WJ-MSC further emerge as promising hypoimmunogenic cells, due to the expression of molecules able to modulate NK cells and expand regulatory T-cell populations. Moreover, it is now accepted that the differentiative capacities of such cells span all the mesoderm-derived tissues, extending to neuroectodermal as well as endodermal lineages. In this review, we compare very recent data on the potential of WJ-MSC to undergo hepatocyte-like differentiation with the results obtained from other adult MSC populations. Data in the literature strongly suggest that WJ-MSC can differentiate into diverse cell types, showing a unique ability to cross lineage borders. This, together with their in vitro proliferative potential and their immunoregulatory features, renders these cells extremely promising for regenerative medicine applications in different pathological settings.

23 October 2010 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
RARita Anzalone
Rita Anzalone
MIMelania Lo Iacono
Melania Lo Iacono
TLTiziana Loria
Tiziana Loria
ASAntonino Di Stefano
Antonino Di Stefano
PGPantaleo Giannuzzi
Pantaleo Giannuzzi
GRGiampiero La Rocca
Giampiero La Rocca

13 August 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
Carla LoretoCarla Loreto
Carla Loreto
GRGiampiero La Rocca
Giampiero La Rocca
RARita Anzalone
Rita Anzalone
Rosario CaltabianoRosario Caltabiano
Rosario Caltabiano
GVGiuseppe Vespasiani
Giuseppe Vespasiani
SSSalvatore Sansalone
Salvatore Sansalone
Peyronie’s disease (PD) is characterized with formation of fibrous plaques which result in penile deformity, pain, and erectile dysfunction. The aim of this study was to investigate the activation of the intrinsic apoptotic pathway in plaques from PD patients. Tunica albuginea from either PD or control patients was assessed for the expression of bax, bcl-2 and caspases 9 and 3 using immunohistochemistry and by measurement of apoptotic cells using TUNEL assay. Bax overexpression was observed in metaplastic bone tissue, in fibroblasts, and in myofibroblast of plaques from PD patients. Little or no bcl-2 immunostaining was detected in samples from either patients or controls. Caspase 3 immunostaining was very strong in fibrous tissue, in metaplasic bone osteocytes, and in primary ossification center osteoblasts. Moderate caspase 9 immunostaining was seen in fibrous cells plaques and in osteocytes and osteoblasts of primary ossification centers from PD patients. Control samples were negative for caspase 9 immunostaining. In PD patients the TUNEL immunoassay showed intense immunostaining of fibroblasts and myofibroblasts, the absence of apoptotic cells in metaplasic bone tissue and on the border between fibrous and metaplastic bone tissue. Apoptosis occurs in stabilized PD plaques and is partly induced by the intrinsic pathway.

1 February 2013 in Current Stem Cell Research & Therapy
Verified
Journal Article
Closed access
PDF file
GRGiampiero La Rocca
Giampiero La Rocca
MIMelania Lo Iacono
Melania Lo Iacono
TCTiziana Corsello
Tiziana Corsello
SCSimona CORRAO
Simona CORRAO
FFFelicia Farina
Felicia Farina
RARita Anzalone
Rita Anzalone
Rheumatoid arthritis and osteoarthritis are the main diseases that imply an inflammatory process at the joints involving the articular cartilage. Recently, mesenchymal stem cells (MSCs) derived from perinatal tissues were considered good candidates for cellular therapy of musculoskeletal and orthopaedic diseases, since they can differentiate into multiple cell types and are an easily accessible cellular source. Therefore, several protocols exist on the differentiation of mesenchymal stem cells of different origins into osteoblasts and chondrocytes. Another key feature of MSCs is their capacity to modulate the immune system responses in vitro and in vivo. This may have critical outcomes in diseases of the musculoskeletal system where an inflammatory or autoimmune process is at the basis of the main disease. In the present paper, after isolation of MSCs from Wharton’s Jelly (WJ-MSCs), we performed the three standard differentiation protocols. The acquisition of the differentiated phenotype was demonstrated by the specific histological stains. As the main objective of this work, we determined the expression of immunomodulatory molecules (by immunohistochemistry and qualitative RT-PCR), both in undifferentiated cells and after differentiation. We demonstrated for the first time that immune-related molecules (as B7-H3/CD276 and HLA-E) which have been characterized in undifferentiated MSCs, are also expressed by the differentiated progeny. This strongly suggests that also after the acquisition of a mature phenotype, WJ-MSCs-derived cells may maintain their immune privilege. This evidence, which deserves much work to be confirmed in vivo and in other MSCs populations, may provide a formal proof of the good results globally achieved with WJMSCs as cellular therapy vehicle.

1 June 2003 in Cancer Letters
Verified
Journal Article
Closed access
Francesco CappelloFrancesco Cappello
Francesco Cappello
Marianna BellafioreMarianna Bellafiore
Marianna Bellafiore
SDSabrina David
Sabrina David
RARita Anzalone
Rita Anzalone
GZGiovanni Zummo
Giovanni Zummo